These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33821321)
41. General method for the quantification of drug loading and release kinetics of nanocarriers. Schwarzl R; Du F; Haag R; Netz RR Eur J Pharm Biopharm; 2017 Jul; 116():131-137. PubMed ID: 28017797 [TBL] [Abstract][Full Text] [Related]
42. Dendritic multishell architectures for drug and dye transport. Quadir MA; Radowski MR; Kratz F; Licha K; Hauff P; Haag R J Control Release; 2008 Dec; 132(3):289-94. PubMed ID: 18639596 [TBL] [Abstract][Full Text] [Related]
43. Nanocarrier-based topical drug delivery for the treatment of skin diseases. Gupta M; Agrawal U; Vyas SP Expert Opin Drug Deliv; 2012 Jul; 9(7):783-804. PubMed ID: 22559240 [TBL] [Abstract][Full Text] [Related]
44. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis. Pople PV; Singh KK Eur J Pharm Biopharm; 2013 May; 84(1):72-83. PubMed ID: 23246619 [TBL] [Abstract][Full Text] [Related]
45. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies. Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737 [TBL] [Abstract][Full Text] [Related]
46. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847 [TBL] [Abstract][Full Text] [Related]
47. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis. Bessar H; Venditti I; Benassi L; Vaschieri C; Azzoni P; Pellacani G; Magnoni C; Botti E; Casagrande V; Federici M; Costanzo A; Fontana L; Testa G; Mostafa FF; Ibrahim SA; Russo MV; Fratoddi I Colloids Surf B Biointerfaces; 2016 May; 141():141-147. PubMed ID: 26852097 [TBL] [Abstract][Full Text] [Related]
48. [Follicular penetration of nanocarriers is an important penetration pathway for topically applied drugs]. Lademann J; Richter H; Schanzer S; Meinke MC; Darvin ME; Schleusener J; Carrer V; Breuckmann P; Patzelt A Hautarzt; 2019 Mar; 70(3):185-192. PubMed ID: 30627746 [TBL] [Abstract][Full Text] [Related]
49. Ethyl cellulose nanocarriers and nanocrystals differentially deliver dexamethasone into intact, tape-stripped or sodium lauryl sulfate-exposed ex vivo human skin - assessment by intradermal microdialysis and extraction from the different skin layers. Döge N; Hönzke S; Schumacher F; Balzus B; Colombo M; Hadam S; Rancan F; Blume-Peytavi U; Schäfer-Korting M; Schindler A; Rühl E; Skov PS; Church MK; Hedtrich S; Kleuser B; Bodmeier R; Vogt A J Control Release; 2016 Nov; 242():25-34. PubMed ID: 27394682 [TBL] [Abstract][Full Text] [Related]
50. Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier. Ramanunny AK; Wadhwa S; Thakur D; Singh SK; Kumar R Endocr Metab Immune Disord Drug Targets; 2021; 21(3):418-433. PubMed ID: 32496998 [TBL] [Abstract][Full Text] [Related]
51. Polyester-Based, Biodegradable Core-Multishell Nanocarriers for the Transport of Hydrophobic Drugs. Walker KA; Stumbé JF; Haag R Polymers (Basel); 2016 May; 8(5):. PubMed ID: 30979288 [TBL] [Abstract][Full Text] [Related]
52. An improved cryopreservation method for porcine buccal mucosa in ex vivo drug permeation studies using Franz diffusion cells. Amores S; Domenech J; Colom H; Calpena AC; Clares B; Gimeno Á; Lauroba J Eur J Pharm Sci; 2014 Aug; 60():49-54. PubMed ID: 24813111 [TBL] [Abstract][Full Text] [Related]
53. Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways. Lapteva M; Santer V; Mondon K; Patmanidis I; Chiriano G; Scapozza L; Gurny R; Möller M; Kalia YN J Control Release; 2014 Dec; 196():9-18. PubMed ID: 25278258 [TBL] [Abstract][Full Text] [Related]
55. Ethosomes as Nanocarriers for the Development of Skin Delivery Formulations. Paiva-Santos AC; Silva AL; Guerra C; Peixoto D; Pereira-Silva M; Zeinali M; Mascarenhas-Melo F; Castro R; Veiga F Pharm Res; 2021 Jun; 38(6):947-970. PubMed ID: 34036520 [TBL] [Abstract][Full Text] [Related]
56. Mucoadhesive Electrospun Patch Delivery of Lidocaine to the Oral Mucosa and Investigation of Spatial Distribution in a Tissue Using MALDI-Mass Spectrometry Imaging. Clitherow KH; Murdoch C; Spain SG; Handler AM; Colley HE; Stie MB; Mørck Nielsen H; Janfelt C; Hatton PV; Jacobsen J Mol Pharm; 2019 Sep; 16(9):3948-3956. PubMed ID: 31361498 [TBL] [Abstract][Full Text] [Related]
58. New easy handling and sampling device for bioavailability screening of topical formulations. Salmon D; Gilbert E; Gioia B; Haftek M; Pivot C; Verrier B; Pirot F Eur J Dermatol; 2015 Apr; 25 Suppl 1():23-9. PubMed ID: 26083671 [TBL] [Abstract][Full Text] [Related]
59. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957 [TBL] [Abstract][Full Text] [Related]
60. The permeability of skin and oral mucosa to water and horseradish peroxidase as related to the thickness of the permeability barrier. Squier CA; Hall BK J Invest Dermatol; 1985 Mar; 84(3):176-9. PubMed ID: 2579163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]